Macular Degeneration Treatment Global Market Report 2024

Global Macular Degeneration Treatment Market Report 2024

Macular Degeneration Treatment Global Market Report 2024 – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By End User (Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals), By Route of Administration (Oral, Injectable, Other Route of Administration), By Types (Wet Macular Degeneration, Dry Macular Degeneration) – Market Size, Trends, And Global Forecast 2024-2033

Name: Macular Degeneration Treatment Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Macular Degeneration Treatment Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 200 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Macular Degeneration Treatment Market Definition

Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). The macular degeneration treatment is used to treat macular degeneration eye disease and slow the disease and prevent severe loss of vision.

The main disease stages in the macular degeneration treatment market are early-stage AMD, intermediate AMD, and late-stage AMD. In early-stage AMD, the macula changes, with medium-sized drusen deposits and no pigment changes, but this does not impact vision. Intermediate AMD is when vision may get blurry or wavy with large drusen or pigment changes. In late-stage AMD, the central vision fails completely, causing vision loss. The different types of macular degeneration treatments include wet macular degeneration and dry macular degeneration. The different routes of administration of macular degeneration treatment include oral, injectable, and others used by different end-users such as ambulatory surgical centers, ophthalmic clinics, and hospitals.

Macular Degeneration Treatment Market Segmentation

The macular degeneration treatment market covered in this report is segmented –

1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

3) By Route of Administration: Oral, Injectable, Other Route of Administration

4) By Types: Wet Macular Degeneration, Dry Macular Degeneration

Global Macular Degeneration Treatment Market Size 2023 to 2028: Graph

Macular Degeneration Treatment Market Size 2024 And Growth Rate

The macular degeneration treatment market size has grown rapidly in recent years. It will grow from $9.74 billion in 2023 to $10.99 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to aging population, lifestyle changes, limited treatment options, rising awareness, healthcare infrastructure development.

Macular Degeneration Treatment Market Growth Forecast

The macular degeneration treatment market size is expected to see rapid growth in the next few years. It will grow to $16.99 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to advancements in research, increased healthcare expenditure, rising incidence rates, personalized medicine approaches, global efforts for vision health. Major trends in the forecast period include focus on neuroprotection and regeneration therapies, expansion of telemedicine and remote monitoring, personalized medicine approaches, investigation of stem cell therapies, patient-focused initiatives for awareness and education.

Book your 30 minutes free consultation with our research experts

Macular Degeneration Treatment Market Driver: Growing Retinal Disorder Incidence Propels Macular Degeneration Treatment Market

The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market. Retinal disorders affect the vital tissue and affect the way individuals process visual information, leading to distorted or absent vision. According to the American Academy of Ophthalmology, in 2050, an estimated 7.32 million people in the United States will have primary open-angle glaucoma, a general term used to describe a group of eye disorders, with the highest numbers among populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The largest demographic group is Hispanic men. Therefore, the increasing burden of retinal disorders is driving the growth of the macular degeneration treatment market.

Macular Degeneration Treatment Market Driver: Rising Aging Population Is Anticipated To Fuel The Macular Degeneration Treatment Market

The rising aging population is expected to propel the growth of the macular degeneration treatment market going forward. An aging population refers to a demographic shift characterized by a higher proportion of elderly individuals within a society or population. Macular degeneration treatment addresses vision impairment in the aging population, targeting a condition affecting the central part of the retina. For instance, in October 2022, according to the World Health Organization, a Switzerland-based Intergovernmental organization, projected that 1 out of every 6 individuals globally would be 60 years old or older by 2030. During this period, the proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Therefore, the rising aging population is driving the macular degeneration treatment market.

Global Macular Degeneration Treatment Market Major Players

Major companies operating in the macular degeneration treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Panoptica, Nidec Pharma Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Valeant Pharmaceuticals, Arrys Therapeutics Inc., Santen Pharmaceuticals, StemCells Inc., Aerie Pharmaceuticals Inc., BioXcel Therapeutics Inc., Regenxbio Inc., Spark Therapeutics Inc., Alimera Sciences Inc., Rxi Pharmaceuticals, Avita Therapeutics Ltd., Applied Genetic Technologies Corp (AGTC), Cell Medica Ltd., Ophthotech Corporation, Adverum Biotechnologies Inc., Neurotech Pharmaceuticals Inc., 4D Molecular Therapeutics Inc., GenSight Biologics Inc., NanOcular Ltd., Codiak BioSciences Inc., Nightstar Therapeutics plc

Global Macular Degeneration Treatment Market Trend: Advancements In Therapies Shape Macular Degeneration Treatment Market

The development of advanced therapies is a key trend gaining popularity in the macular degeneration treatment market. Advanced therapy, including gene therapy, for the treatment of disease has seen development in recent years, particularly in the world of inherited retinal disease. For instance, in October 2021, Genentech, a US-based biotechnology company, announced that FDA has approved Susvimo, a new treatment for wet age-related macular degeneration. Susvimo is the first wet AMD treatment to offer an alternative to the standard-of-care eye injections required as frequently as once per month in the last 15 years. Susvimo will help people with wet AMD retain their vision with as few as two treatments per year by continually injecting medication into the eye via a refillable implant.

Global Macular Degeneration Treatment Market Trend: Innovative Solutions Enhanced Macular Degeneration Treatment

Major companies in the macular degeneration treatment market are focused on developing innovative solutions, such as avacincaptad pegol intravitreal solution, for geographic atrophy, and maximizing their profits in the market. Avacincaptad pegol intravitreal solution is a complement C5 inhibitor for treating geographic atrophy secondary. For instance, in August 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, received FDA approval for IZERVAY, an avacincaptad pegol intravitreal solution for treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). IZERVAY, a complement C5 inhibitor, demonstrated a statistically significant reduction in GA progression at the 12-month primary endpoint in two Phase 3 clinical trials, with photoreceptor loss slowing as early as six months.

Macular Degeneration Treatment Market Merger And Acquisition:

Novartis Expands Vision Loss Solutions With Acquisition Of Arctos Medical

In September 2021, Novartis, a Swiss-based pharmaceutical company, acquired Arctos Medical for an undisclosed amount. The acquisition is expected to allow Novartis to find treatments for patients with vision loss and leverage the potential of optogenetics as the basis of successful therapeutics. Arctos Medical is a Switzerland-based developer of smart medical devices and gene therapy approaches for ophthalmological diseases for treating blindness.

Regional Insights For The Global Macular Degeneration Treatment Market

North America was the largest region in the macular degeneration treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment market market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the macular degeneration treatment market market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The macular degeneration treatment market includes revenues earned by entities by anti-angiogenic drugs, photodynamic therapy, laser therapy and low vision aids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The macular degeneration treatment research report is one of a series of new reports from The Business Research Company that provides macular degeneration treatment statistics, including macular degeneration treatment industry global market size, regional shares, competitors with macular degeneration treatment shares, detailed macular degeneration treatment segments, market trends and opportunities, and any further data you may need to thrive in the macular degeneration treatment industry. This macular degeneration treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Macular Degeneration Treatment Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$10.99 billion
Revenue Forecast In 2033	$16.99 billion
Growth Rate	CAGR of 11.5% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD 2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals 3) By Route of Administration: Oral, Injectable, Other Route of Administration 4) By Types: Wet Macular Degeneration, Dry Macular Degeneration
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Allergan Inc.; Bayer AG; Novartis AG; GlaxoSmithKline plc; Panoptica; Nidec Pharma Inc.; Regeneron Pharmaceuticals Inc.; Bausch Health Companies Inc.; Valeant Pharmaceuticals; Arrys Therapeutics Inc.; Santen Pharmaceuticals; StemCells Inc.; Aerie Pharmaceuticals Inc.; BioXcel Therapeutics Inc.; Regenxbio Inc.; Spark Therapeutics Inc.; Alimera Sciences Inc.; Rxi Pharmaceuticals; Avita Therapeutics Ltd.; Applied Genetic Technologies Corp. (AGTC); Cell Medica Ltd.; Ophthotech Corporation; Adverum Biotechnologies Inc.; Neurotech Pharmaceuticals Inc.; 4D Molecular Therapeutics Inc.; GenSight Biologics Inc.; NanOcular Ltd.; Codiak BioSciences Inc.; Nightstar Therapeutics plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Macular Degeneration Treatment Market Characteristics

3. Macular Degeneration Treatment Market Trends And Strategies

4. Macular Degeneration Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Macular Degeneration Treatment Market Size and Growth

5.1. Global Macular Degeneration Treatment Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Macular Degeneration Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Macular Degeneration Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Macular Degeneration Treatment Market Segmentation

6.1. Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Wet Macular Degeneration

Dry Macular Degeneration

6.2. Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Early-Stage AMD

Intermediate AMD

Late-Stage AMD

6.3. Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oral

Injectable

Other Route of Administration

6.4. Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Ambulatory Surgical Centers

Ophthalmic Clinics

Hospitals

7. Macular Degeneration Treatment Market Regional And Country Analysis

7.1. Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Macular Degeneration Treatment Market

8.1. Asia-Pacific Macular Degeneration Treatment Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Macular Degeneration Treatment Market

9.1. China Macular Degeneration Treatment Market Overview

9.2. China Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Macular Degeneration Treatment Market

10.1. India Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Macular Degeneration Treatment Market

11.1. Japan Macular Degeneration Treatment Market Overview

11.2. Japan Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Macular Degeneration Treatment Market

12.1. Australia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Macular Degeneration Treatment Market

13.1. Indonesia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Macular Degeneration Treatment Market

14.1. South Korea Macular Degeneration Treatment Market Overview

14.2. South Korea Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Macular Degeneration Treatment Market

15.1. Western Europe Macular Degeneration Treatment Market Overview

15.2. Western Europe Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Macular Degeneration Treatment Market

16.1. UK Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Macular Degeneration Treatment Market

17.1. Germany Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Macular Degeneration Treatment Market

18.1. France Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Macular Degeneration Treatment Market

19.1. Italy Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Macular Degeneration Treatment Market

20.1. Spain Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Macular Degeneration Treatment Market

21.1. Eastern Europe Macular Degeneration Treatment Market Overview

21.2. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Macular Degeneration Treatment Market

22.1. Russia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Macular Degeneration Treatment Market

23.1. North America Macular Degeneration Treatment Market Overview

23.2. North America Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Macular Degeneration Treatment Market

24.1. USA Macular Degeneration Treatment Market Overview

24.2. USA Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Macular Degeneration Treatment Market

25.1. Canada Macular Degeneration Treatment Market Overview

25.2. Canada Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Macular Degeneration Treatment Market

26.1. South America Macular Degeneration Treatment Market Overview

26.2. South America Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Macular Degeneration Treatment Market

27.1. Brazil Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Macular Degeneration Treatment Market

28.1. Middle East Macular Degeneration Treatment Market Overview

28.2. Middle East Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Macular Degeneration Treatment Market

29.1. Africa Macular Degeneration Treatment Market Overview

29.2. Africa Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Macular Degeneration Treatment Market Competitive Landscape And Company Profiles

30.1. Macular Degeneration Treatment Market Competitive Landscape

30.2. Macular Degeneration Treatment Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. F. Hoffmann-La Roche Ltd.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Allergan Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Bayer AG

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Novartis AG

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Macular Degeneration Treatment Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc

31.2. Panoptica

31.3. Nidec Pharma Inc.

31.4. Regeneron Pharmaceuticals Inc.

31.5. Bausch Health Companies Inc.

31.6. Valeant Pharmaceuticals

31.7. Arrys Therapeutics Inc.

31.8. Santen Pharmaceuticals

31.9. StemCells Inc.

31.10. Aerie Pharmaceuticals Inc.

31.11. BioXcel Therapeutics Inc.

31.12. Regenxbio Inc.

31.13. Spark Therapeutics Inc.

31.14. Alimera Sciences Inc.

31.15. Rxi Pharmaceuticals

32. Global Macular Degeneration Treatment Market Competitive Benchmarking

33. Global Macular Degeneration Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market

35. Macular Degeneration Treatment Market Future Outlook and Potential Analysis

35.1 Macular Degeneration Treatment Market In 2028 - Countries Offering Most New Opportunities

35.2 Macular Degeneration Treatment Market In 2028 - Segments Offering Most New Opportunities

35.3 Macular Degeneration Treatment Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Pfizer Inc. Financial Performance

Table 76: F. Hoffmann-La Roche Ltd. Financial Performance

Table 77: Allergan Inc. Financial Performance

Table 78: Bayer AG Financial Performance

Table 79: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Pfizer Inc. Financial Performance

Figure 76: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 77: Allergan Inc. Financial Performance

Figure 78: Bayer AG Financial Performance

Figure 79: Novartis AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Gastrointestinal Bleeding Treatment Devices Global Market Report 2024 – By Product (Endoscopic Thermal Devices, Other Products), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End User (Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastrointestinal Devices Global Market Report 2024 – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), By Sales Channel (Online Retailing, Medical Stores & Brand Outlet), By End Users (Hospitals, Clinics & Dialysis Centers, Ambulatory Surgical Center) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Medical Equipment Maintenance Global Market Report 2024 – By Service Type (Preventive Maintenance, Corrective Maintenance, Operational Maintenance), By Device (Imaging Equipment, Endoscopic Devices, Surgical Instruments, Electro-medical Equipment), By Technology (Multi-Vendor OEMs, Single-Vendor OEMs, Independent Service Organization, In-House Maintenance), By End User (Hospital, Diagnostic Imaging Centers, Dialysis Centers, Ambulatory Surgical Centers, Dental Clinics And Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biosimilar Therapeutic Peptides Global Market Report 2024 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Hemodialysis And Peritoneal Dialysis Global Market Report 2024 – By Type (Hemodialysis, Short-Term Catheter, Chronic Catheter, Graft, Fistula, Peritoneal Dialysis), By Modality (Conventional, Daily (Day Time, Night Time)), By End User (Hospitals, Clinics, And Dialysis Centers, Home Dialysis) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Endoscopy Devices And Equipment Global Market Report 2024 – By Product (Endoscope, Endoscopy Operative Devices, Endoscopy Visualization Systems), By Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Obstetrics/Gynecology Endoscopy, ENT Endoscopy, Other Applications), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Medication Adherence Global Market Report 2024 – By Type (Hardware Centric, Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology, Other Medications), By Application (Hospital, Retail Pharmacies, Long-Term Care Facilities, Mail-Order Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dialysis Devices And Equipment Global Market Report 2024 – By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the macular degeneration treatment market?

How will the macular degeneration treatment market drivers and restraints affect the macular degeneration treatment market dynamics? What forces will shape the macular degeneration treatment industry going forward?

The macular degeneration treatment market major growth driver - growing retinal disorder incidence propels macular degeneration treatment market. For further insights on the macular degeneration treatment market, request a sample here

What is the forecast market size or the forecast market value of the macular degeneration treatment market ?

The macular degeneration treatment market size has grown rapidly in recent years. It will grow from $9.74 billion in 2023 to $10.99 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to aging population, lifestyle changes, limited treatment options, rising awareness, healthcare infrastructure development. The macular degeneration treatment market size is expected to see rapid growth in the next few years. It will grow to $16.99 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to advancements in research, increased healthcare expenditure, rising incidence rates, personalized medicine approaches, global efforts for vision health. Major trends in the forecast period include focus on neuroprotection and regeneration therapies, expansion of telemedicine and remote monitoring, personalized medicine approaches, investigation of stem cell therapies, patient-focused initiatives for awareness and education. For further insights on the macular degeneration treatment market, request a sample here

How is the macular degeneration treatment market segmented?

The macular degeneration treatment market is segmented
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
3) By Route of Administration: Oral, Injectable, Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration For further insights on the macular degeneration treatment market, request a sample here

Which region has the largest share of the macular degeneration treatment market? What are the other regions covered in the report?

North America was the largest region in the macular degeneration treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment market market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the macular degeneration treatment market, request a sample here.

Who are the major players in the macular degeneration treatment market?

What are the key trends in the macular degeneration treatment market?

Major trend in the macular degeneration treatment market - innovative solutions enhanced macular degeneration treatment. For further insights on the macular degeneration treatment market, request a sample here.

What are the major opportunities in the macular degeneration treatment market? What are the strategies for the macular degeneration treatment market?

For detailed insights on the major opportunities and strategies in the macular degeneration treatment market, request a sample here.

How does the macular degeneration treatment market relate to the overall economy and other similar markets?

For detailed insights on macular degeneration treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the macular degeneration treatment industry?

For detailed insights on the mergers and acquisitions in the macular degeneration treatment industry, request a sample here.

What are the key dynamics influencing the macular degeneration treatment market growth? SWOT analysis of the macular degeneration treatment market.

For detailed insights on the key dynamics influencing the macular degeneration treatment market growth and SWOT analysis of the macular degeneration treatment industry, request a sample here.